CYP3A4 and hepatocellular carcinoma: Therefore, AURKA, PRC1, TOP2A, AOX1, CYP2E1, and CYP3A4 can be considered candidate liver-biopsy markers for high risk of developing HCC and poor prognosis in HCC.